BC

Balchem CorpNASDAQ BCPC Stock Report

Last reporting period 30 Sep, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

5.691

Middle

Exchange

XNAS - Nasdaq

BCPC Stock Analysis

BC

Avoid

Based on Eyestock quantitative analysis, BCPC`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

84/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-9.0 %

Greatly overvalued

Market cap $B

5.691

Dividend yield

0.54 %

Shares outstanding

32.169 B

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company’s segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies, in addition to nutrient choline chloride. Through Specialty Products, it provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

View Section: Eyestock Rating